Related Experiment Video
Updated: Jul 30, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Overview of modern approaches for identifying and evaluating heterogeneous treatment effects from clinical data
Ilya Lipkovich1, David Svensson2, Bohdana Ratitch3
1Eli Lilly and Company, Indianapolis, IN, USA.
Abstract:
There has been much interest in the evaluation of heterogeneous treatment effects (HTE) and multiple statistical methods have emerged under the heading of personalized/precision medicine combining ideas from hypothesis testing, causal inference, and machine learning over the past 10-15 years. We discuss new ideas and approaches for evaluating HTE in randomized clinical trials and observational studies using the features introduced earlier by Lipkovich, Dmitrienko, and D'Agostino that distinguish principled methods from simplistic approaches to data-driven subgroup identification and estimating individual treatment effects and use a case study to illustrate these approaches. We identified and provided a high-level overview of several classes of modern statistical approaches for personalized/precision medicine, elucidated the underlying principles and challenges, and compared findings for a case study across different methods. Different approaches to evaluating HTEs may produce (and actually produced) highly disparate results when applied to a specific data set. Evaluating HTE with machine learning methods presents special challenges since most of machine learning algorithms are optimized for prediction rather than for estimating causal effects. An additional challenge is in that the output of machine learning methods is typically a "black box" that needs to be transformed into interpretable personalized solutions in order to gain acceptance and usability.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Comparing the Survival Analysis of Two or More Groups
Hazard Ratio
For example, in a clinical trial...
Analysis of Population Pharmacokinetic Data

